Why You Should Take CPT Hip System Femoral Stem Recall Seriously
Why You Should Take the CPT Hip System Femoral Stem Recall Seriously
On July 8, 2024, the Canadian government issues a communication concerning a recall for the CPT Hip System Femoral Stem 12/14 Neck Taper. As we reported elsewhere, Zimmer Biomet manufactured this medical device.
The recall addresses an increased risk of postoperative periprosthetic femoral fracture (PFF) among patients who have undergone hip replacement surgery with this device. This risk affects anyone who has received the CPT Hip System. The affected products span all lots and include various models. These types of fractures can cause severe pain, loss of mobility, and the need for further corrective surgeries.
The recall, categorized as a Type II health product recall, highlights how serious this issue is for both patients and healthcare providers.
The Canadian government, through Health Canada, has made this recall a priority. It endeavors to make Health professionals across the country aware of the need to monitor patients who have had this implant. The government issued alerts to ensure surgeons, patients, and hospitals take the necessary precautions and schedule follow-ups to address any issues early. But the potential harm is not limited to Canada. This recall has global implications because these devices are widely available for use in the U.S. and other countries.
Why This Recall Should Be a Global Concern
While Canada has taken swift and decisive action, the U.S. government is also keeping a close eye on the situation. The FDA, which monitors the safety of medical devices in the U.S., is closely collaborating with manufacturers and healthcare professionals to determine the scale of the issue in American patients. However, the U.S. healthcare system may sometimes move slower when it comes to widespread recalls. This is due to more complex regulatory and legal processes. The Zimmer Biomet CPT Hip System is no stranger to scrutiny in the U.S. Patients have already reported complications, including PFF. The recall in Canada reinforces the fact that this is not an isolated issue.
Just like Canada, the U.S. must prioritize the health and safety of its citizens when it comes to medical device recalls. The Zimmer Biomet hip system is used worldwide. Patients in both countries deserve the same level of protection and care. Canada’s immediate response serves as a model for how governments should act when faced with a medical device that poses a risk to public health. The U.S. FDA should continue its collaboration with Health Canada, Zimmer Biomet, and healthcare providers to ensure that this recall is enforced with the same urgency.
There are reports in both countries of patients experiencing device-related complications that significantly impacted their lives. Postoperative periprosthetic femoral fractures are not minor inconveniences. These fractures can lead to months of rehabilitation, multiple surgeries, and the inability to return to everyday activities. Both the U.S. and Canada need to ensure that patients have the support they need to address these concerns. With both nations working together, they can help prevent further injuries. They can also promote awareness, and ensure that all patients are properly informed and treated.
The Consequences of the CPT Hip System Femoral Stem for American Patients
In the U.S., many patients who received the CPT Hip System have reported severe complications. Some have had to undergo painful revision surgeries. The increased risk of fractures means that many patients face a higher chance of enduring excruciating pain. With this also comes risk of difficulty walking, and potential long-term disability. For some, the financial burden of repeat surgeries, physical therapy, and the cost of missed work has been overwhelming.
Many of these patients trusted that their hip replacement surgery would improve their quality of life. Instead, they found themselves dealing with unforeseen consequences. The emotional toll of dealing with this type of injury cannot be understated.
Imagine waking up after surgery only to learn that the device intended to help you has failed and requires yet another operation. It can feel like an endless cycle of pain and uncertainty, which no patient should have to endure.
The Zimmer Biomet recall is a wake-up call for every American who has received this implant or knows someone who has. The health complications that stem from this device are real. Every person who this could affect needs to take this recall seriously. This is not just a Canadian problem or a U.S. problem—it’s a global issue.
How KBA Attorneys Can Help
If you or a loved one has suffered from complications due to the CPT Hip System Femoral Stem, KBA Attorneys can help you. Our team understands how devastating it can be to experience pain and suffering from a device that is supposed to improve your life. We have years of experience handling medical device injury cases, and we fight to make sure our clients get the compensation they deserve.
You deserve more than just medical care—you deserve justice. Whether it’s helping you cover your medical costs, lost wages, or pain and suffering, we are here to guide you through every step of the legal process. Our goal is to ensure that those responsible for putting unsafe products on the market take accountability. Don’t wait until it’s too late—contact us today for a free consultation and let us help you find the resolution you deserve.
This recall is about more than just hip replacement devices. It’s about people who trusted the healthcare system to protect them, only to be let down. Don’t wait until your pain becomes unbearable. If you or someone you know has been affected by this recall, take action now and protect your health and your future.